BRASILIA (Reuters) – Brazil’s health regulator Anvisa on Friday recommended the approval of a second emergency use request of China’s CoronaVac vaccine, which would allow for the use of 4.8 million doses that were partly manufactured in Brazil.
Brazil has already approved a first emergency request for the use of Sinovac’s CoronaVac to cover 6 million doses that were imported from China.
(Reporting by Ricardo Brito and Lisandra Paraguassu, Editing by Rosalba O’Brien)
